Filing Details
- Accession Number:
- 0000930413-10-004315
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-06 13:00:00
- Reporting Period:
- 2010-08-05
- Filing Date:
- 2010-08-06
- Accepted Time:
- 2010-08-06 19:17:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1387811 | H B Stephen Kent | C/O Enzo Biochem, Inc. 527 Madison Avenue New York City NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Disposition | 2010-08-05 | 300 | $4.46 | 19,854 | No | 4 | S | Direct | |
Common Stock, Par Value $0.01 Per Share | Disposition | 2010-08-05 | 1,500 | $4.47 | 18,354 | No | 4 | S | Direct | |
Common Stock, Par Value $0.01 Per Share | Disposition | 2010-08-05 | 700 | $4.48 | 17,654 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |